Education
About Us
Working with TipRanks
Follow Us
Aurobindo Pharma Ltd (IN:AUROPHARMA)
:AUROPHARMA
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | ₹ 317.24B | ₹ 290.02B | ₹ 248.55B | ₹ 234.55B | ₹ 247.75B |
| Gross Profit | ₹ 182.40B | ₹ 160.16B | ₹ 132.14B | ₹ 130.06B | ₹ 145.85B |
| Operating Income | ₹ 120.01B | ₹ 104.50B | ₹ 81.05B | ₹ 78.06B | ₹ 94.03B |
| EBITDA | ₹ 64.36B | ₹ 57.64B | ₹ 36.34B | ₹ 43.11B | ₹ 53.95B |
| Net Income | ₹ 34.86B | ₹ 31.73B | ₹ 19.27B | ₹ 26.48B | ₹ 53.35B |
| Balance Sheet | |||||
| Cash & Short-Term Investments | ₹ 82.36B | ₹ 63.25B | ₹ 62.24B | ₹ 45.58B | ₹ 56.21B |
| Total Assets | ₹ 497.85B | ₹ 450.72B | ₹ 398.90B | ₹ 339.22B | ₹ 338.54B |
| Total Debt | ₹ 82.63B | ₹ 66.48B | ₹ 52.86B | ₹ 32.79B | ₹ 53.39B |
| Net Debt | ₹ 273.80M | ₹ 32.54B | ₹ 8.90B | ₹ -8.84B | ₹ -343.90M |
| Total Liabilities | ₹ 171.38B | ₹ 152.21B | ₹ 130.38B | ₹ 93.48B | ₹ 119.25B |
| Stockholders' Equity | ₹ 326.53B | ₹ 298.43B | ₹ 268.40B | ₹ 245.76B | ₹ 219.30B |
| Cash Flow | |||||
| Free Cash Flow | ₹ 19.57B | ₹ -11.27B | ₹ -3.34B | ₹ 23.12B | ₹ 14.55B |
| Operating Cash Flow | ₹ 39.25B | ₹ 24.35B | ₹ 23.87B | ₹ 50.16B | ₹ 33.29B |
| Investing Cash Flow | ₹ -18.76B | ₹ -42.56B | ₹ -39.78B | ₹ -32.12B | ₹ 5.99B |
| Financing Cash Flow | ₹ 1.20B | ₹ 8.00B | ₹ 18.14B | ₹ -29.69B | ₹ -13.65B |